Bionano Genomics Inc
Change company Symbol lookup
Select an option...
BNGO Bionano Genomics Inc
GOLD Barrick Gold Corp
CLPS CLPS Inc
SIOX Sio Gene Therapies Inc
NSTB Northern Star Investment Corp II
ALKS Alkermes Plc
CPTNW Cepton Equity Warrant Exp 10th Feb 2027 *W EXP 02/10/2027
APPF Appfolio Inc
FMN Federated Hermes Premier Municipal Inc
USCTU TKB Critical Technologies 1
Go

Health Care : Life Sciences Tools & Services | Small Cap Growth
Company profile

Bionano Genomics, Inc. is a genomics company, which provides optical genome mapping (OGM) for genome analysis. The Company offers diagnostic services to physicians specializing in medical management for individuals with genetic conditions, such as pediatric neurodevelopmental disorders, including autism spectrum disorders. It markets and sell the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation. Its Lineagen business provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. Through its BioDiscovery business, it offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants and absence of heterozygosity across the genome in one consolidated view.

Premarket

Last Trade
Delayed
$1.81
0.04 (2.26%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$1.77
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
78,612

10-day average volume:
6,896,190
78,612

BNGO's position in the Life Sciences Tools & Services industry

Industry PeersBNGOTXGPACB

Summary

Company ProfileBionano Genomics, Inc. is a genomics company, which provides optical genome mapping (OGM) for genome analysis. The Company offers diagnostic services to physicians specializing in medical management...
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables, and software for analyzing biological systems. Its products include...
Go to TXG summary
Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers...
Go to PACB summary
52-Week Change

VS. INDUSTRY
-16.90%
-47.44%
4.42%
Market Cap

VS. INDUSTRY
$525.6M
$5.4B
$2.8B
Beta

VS. INDUSTRY
2.3
1.7
1.6
Dividend Yield

VS. INDUSTRY
--
--
--
P/E (TTM, GAAP)

VS. INDUSTRY
--
--
--
Data as of

Fundamentals

Total Revenue (TTM)

VS. INDUSTRY
$25.9M
$503.7M
$137.0M
Profit Margin

VS. INDUSTRY
-451.42%
-33.20%
-218.44%
Earnings Growth
(5 year, GAAP)

VS. INDUSTRY
--
--
--
Revenue Growth (TTM)

VS. INDUSTRY
65.22%
9.70%
12.61%
Data as of
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.